According to the Wall Street Journal, a study by property group Marks & Clerk has revealed that pharmaceutical and biotechnology industry mergers and acquisitions are set to rise.
The poll found that nearly 7 in 10 predicted increasing acquisition activity in the pharmaceutical and biotech sectors within the next 2 years.
“Pharmaceutical companies may now have confidence and the support of institutional investors to press ahead with acquisitions although at this stage, selecting the right acquisition targets will be critical to their future R&D success,” said Gareth Williams, Partner at Marks & Clerk.
“This may explain the 84% who believe the market is now confident to plough forward with strategic collaborations – they are determined to cherry-pick the best targets, while increasing reliance on patent term extensions buys them some vital time ahead of making a move. What is being predicted is not necessarily driven so much by desire as urgency,” Williams said.
Looking for a job in the pharmaceutical or biotechnology industries? Click here to search our current pharmaceutical and biotech jobs now.